Get the Stockscreener App
364.29
0.89%
3.4229
Why is United Therapeutics Corp (UTHR) Stock down?
We've noticed a 5.83% decline in United Therapeutics Corp (UTHR) stock during the 2024-12-18 trading session. While this could be attributed to normal volatility or various internal and external factors, please be aware that we are actively monitoring the situation, and we'll provide timely updates as soon as possible!
28 Mar, 2024:
United Therapeutics Corp (UTHR) fell by 5.57% due to a report by GuruFocus Research. This decline may have been influenced by various factors, including market sentiment and investor reactions to recent developments within the company.
- Insider Selling Activity: Martine Rothblatt, the Chairperson & Chief Executive Officer of UTHR, sold 29,125 shares of the company on March 28, 2024, according to a recent SEC filing. This insider selling activity may have contributed to the negative sentiment surrounding UTHR stock.
- Insider Transaction Trends: The insider trend for UTHR indicates a consistent pattern of sales by insiders over the past year, with 54 insider sells and no buys during this period. Investors often monitor insider transaction trends as they can provide insights into insiders' perspectives on the value of the company's stock.
- Impact on stock's price: The insider selling influented the stock's price as investors raised concerns about the company and stock itself.
0.05%
0.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):